Bank of America
BIVV

Bank of America’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Bank of America’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,800
Closed -$259K – 7547
2017
Q4 		$259K Sell
4,800
-17,100
-78% -$936K ﹤0.01% 5291
2017
Q3 		$1.25M Sell
21,900
-90,000
-80% -$5.27M ﹤0.01% 4359
2017
Q2 		$6.73M Buy
111,900
+90,000
+411% +$5.13M ﹤0.01% 2750
2017
Q1 		$1.19M Buy
+21,900
New +$1.08M ﹤0.01% 4317

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Bank of America's BIVV Position: Q1 2018 in Review

Bank of America sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 452,808 shares — an estimated $24.4M sold.

Bank of America first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $29.9M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Bank of America reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Bank of America sold 452,808 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $24.4M.
  • Bank of America first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Bank of America's Bioverativ Inc. Common Stock position peaked at $29.9M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.